190 related articles for article (PubMed ID: 32931953)
1. Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators.
Gómez-Coronado D; Lasunción MA; Martínez-Botas J; Fernández-Suárez ME
Semin Cancer Biol; 2021 Aug; 73():101-115. PubMed ID: 32931953
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR.
Fernández-Suárez ME; Daimiel L; Villa-Turégano G; Pavón MV; Busto R; Escolà-Gil JC; Platt FM; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
Biomed Pharmacother; 2021 Sep; 141():111871. PubMed ID: 34225017
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
Sengupta S; Jordan VC
Adv Exp Med Biol; 2008; 630():206-19. PubMed ID: 18637493
[TBL] [Abstract][Full Text] [Related]
4. Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.
DuSell CD; Nelson ER; Wittmann BM; Fretz JA; Kazmin D; Thomas RS; Pike JW; McDonnell DP
Mol Endocrinol; 2010 Jan; 24(1):33-46. PubMed ID: 19901195
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
Park WC; Jordan VC
Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
[TBL] [Abstract][Full Text] [Related]
6. Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.
Fan P; Craig Jordan V
Steroids; 2014 Nov; 90():44-52. PubMed ID: 24930824
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Musa MA; Khan MO; Cooperwood JS
Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
[TBL] [Abstract][Full Text] [Related]
8. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor modulation--role of coregulators in selective estrogen receptor modulator (SERM) actions.
Feng Q; O'Malley BW
Steroids; 2014 Nov; 90():39-43. PubMed ID: 24945111
[TBL] [Abstract][Full Text] [Related]
10. Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.
Fernández-Suárez ME; Escolà-Gil JC; Pastor O; Dávalos A; Blanco-Vaca F; Lasunción MA; Martínez-Botas J; Gómez-Coronado D
Sci Rep; 2016 Sep; 6():32105. PubMed ID: 27601313
[TBL] [Abstract][Full Text] [Related]
11. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.
Peng J; Sengupta S; Jordan VC
Anticancer Agents Med Chem; 2009 Jun; 9(5):481-99. PubMed ID: 19519291
[TBL] [Abstract][Full Text] [Related]
12. Selective Estrogen Receptor Modulators (SERMs) Synergize with Cisplatin, Induce Apoptosis and Suppress Cellular Migration and Colony Formation of Lung Cancer Cells.
Alsous L; Bardaweel S
Anticancer Agents Med Chem; 2022; 22(9):1826-1836. PubMed ID: 35546505
[TBL] [Abstract][Full Text] [Related]
13. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Thiebaud D; Secrest RJ
Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism.
Shim JS; Li RJ; Lv J; Head SA; Yang EJ; Liu JO
Cancer Lett; 2015 Jun; 362(1):106-15. PubMed ID: 25799952
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
Dutertre M; Smith CL
J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
[TBL] [Abstract][Full Text] [Related]
17. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
Jirecek S; Pavo I; Huber JC
Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
19. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
20. From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).
Wardell SE; Nelson ER; McDonnell DP
Steroids; 2014 Nov; 90():30-8. PubMed ID: 25084324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]